Publications by authors named "Heidy Cabral"

Claim this Profile
O
One-Year Comparative Effectiveness and Safety of Upadacitinib vs Risankizumab for Crohn's Disease.
Rahul S Dalal, Alexander D Carlin, Heidy J Cabral, Lindsay M Clarke, Grace B Hardwick

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual Health Concerns and Health Care Experiences of LGBTQ+ Patients with Inflammatory Bowel Disease.
Taylor Boyd, Sonia Friedman, Kira L Newman, Victor Chedid, Heidy Judith Cabral

Inflamm Bowel Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Comparative Effectiveness of Vedolizumab Versus Upadacitinib for Crohn's Disease Through 52 Weeks.
Rahul S Dalal, Alex Carlin, Heidy Cabral, Grace B Hardwick, Lindsay M Clarke

J Clin Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series.
Rahul S Dalal, Lindsay M Clarke, Heidy J Cabral, Alexander D Carlin, Grace B Hardwick

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis.
Rahul S Dalal, Lindsay M Clarke, Alex Carlin, Heidy Cabral, Jessica R Allegretti

Inflamm Bowel Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Dose Intensification of Risankizumab for Crohn's Disease.
Rahul S Dalal, Heidy J Cabral, Alex Carlin, Matthew P Ilse, Jessica R Allegretti

Clin Gastroenterol Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Rahul S Dalal, Govind Kallumkal, Heidy J Cabral, Salam Bachour, Edward L Barnes

Inflamm Bowel Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study.
Rahul S Dalal, Govind Kallumkal, Heidy J Cabral, Edward L Barnes, Jessica R Allegretti

Am J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Rahul S Dalal, Govind Kallumkal, Heidy J Cabral, Salam Bachour, Edward L Barnes

Clin Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling root system growth around obstacles.
Wencheng Jin, Jayde Aufrecht, Fernando Patino-Ramirez, Heidy Cabral, Chloé Arson

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis